MarketsandMarkets Blog

The global antimicrobial resistance surveillance market is projected to reach USD 7.7 billion by 2028 from USD 5.9 billion in 2023, at a CAGR of 5.6% during the forecast period. Growth in this market is majorly driven by factors such as the growing prevalence of infections caused by drug-resistance pathogens, innovations in diagnostic technologies and growing government initiatives to combat antimicrobial-resistance...

Antimicrobial resistance (AMR) is one of the most pressing public health challenges of the 21st century. It occurs when bacteria, viruses, fungi, and parasites evolve to resist the drugs designed to kill them, rendering standard treatments ineffective and leading to prolonged illness, higher medical costs, and increased mortality. Effective surveillance systems are crucial in monitoring and combating...

The threat of antibiotic-resistant bacteria, often referred to as “superbugs,” is a growing global health crisis. As these resilient pathogens continue to evade our most potent antimicrobial weapons, the need for robust surveillance systems has become increasingly critical. This emerging market is poised to play a vital role in monitoring and containing the spread of these formidable foes. Valued...